Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy (Q39381586)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy
scientific article

    Statements

    Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy (English)
    Celina García-García
    Yasir H Ibrahim
    Maria Teresa Calvo
    Christian Rommel
    Maurizio Scaltriti

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit